Mutations in the PIK3CA p85 BD were also frequently identified (>20%) in uterine tumour samples profiled by The Cancer Genome Atlas (TCGA) network (Fig. 3e), paralleling the cell line data17. This evidence concerns the gene PIK3CA and tumor of uterus.